Review



human umbilical artery smcs huasmcs  (PromoCell)


Bioz Verified Symbol PromoCell is a verified supplier
Bioz Manufacturer Symbol PromoCell manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    PromoCell human umbilical artery smcs huasmcs
    Human Umbilical Artery Smcs Huasmcs, supplied by PromoCell, used in various techniques. Bioz Stars score: 94/100, based on 43 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+umbilical+artery+smcs+huasmcs/HUASMC-c+Human+Umbilical+Artery+Smooth+Muscle+Cells/pm14597670-34-25-33
    Average 94 stars, based on 43 article reviews
    human umbilical artery smcs huasmcs - by Bioz Stars, 2026-09
    94/100 stars

    Images

    Related Articles

    Cell Culture:

    Article Title: Intrinsic versus microenvironmental regulation of lymphatic endothelial cell phenotype and function.
    Article Snippet: Vascular endothelial cells are characterized by a high degree of functional and phenotypic plasticity, which is controlled both by their pericellular microenvironment and their intracellular gene expression programs.. To gain further insight into the mechanisms regulating the endothelial cell phenotype, we have compared the responses of lymphatic endothelial cells (LECs) and blood vascular endothelial cells (BECs) to vascular endothelial growth factors (VEGFs).. VEGFR-3-specific signals are sufficient for LEC but not BEC proliferation, as shown by the ability of the specific ligand VEGF-C156S to stimulate cell cycle entry only in LECs.



    Similar Products

    human umbilical artery smcs huasmcs  (PromoCell)
    94
    PromoCell human umbilical artery smcs huasmcs
    Human Umbilical Artery Smcs Huasmcs, supplied by PromoCell, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+umbilical+artery+smcs+huasmcs/HUASMC-c+Human+Umbilical+Artery+Smooth+Muscle+Cells/pm14597670-34-25-33
    Average 94 stars, based on 1 article reviews
    human umbilical artery smcs huasmcs - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier
    human umbilical artery smcs huasmcs  (Procell Inc)
    86
    Procell Inc human umbilical artery smcs huasmcs
    Effects of bare and coating-modified groups on <t>SMCs</t> proliferation. (A–C) Representative fluorescence images of <t>HUASMCs</t> cytoskeleton (red) and nucleus (blue) after 24 and 72 h of different treatments, including untreated control group, bare group, MgF 2 -coated group, MgF 2 /PU-coated group, and MgF 2 /PU/PTV-coated group (A), along with quantitative cell viability assessments at 24 h (B) and 72 h (C). (D–E) Relative mRNA expression levels of α-SMA (D), VCAM-1(E), as determined by qPCR analysis. One-way ANOVA followed by Tukey's multiple comparison test was performed to determine statistical significance. Data are presented as mean ± SD, with p -values <0.05 considered statistically significant (n = 3). ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.
    Human Umbilical Artery Smcs Huasmcs, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+umbilical+artery+smcs+huasmcs/cells+endothelial+human+umbilical+vein/pmc12433515-134-5-15
    Average 86 stars, based on 1 article reviews
    human umbilical artery smcs huasmcs - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    human umbilical artery smooth muscle cells smcs  (PromoCell)
    94
    PromoCell human umbilical artery smooth muscle cells smcs
    Effects of bare and coating-modified groups on <t>SMCs</t> proliferation. (A–C) Representative fluorescence images of <t>HUASMCs</t> cytoskeleton (red) and nucleus (blue) after 24 and 72 h of different treatments, including untreated control group, bare group, MgF 2 -coated group, MgF 2 /PU-coated group, and MgF 2 /PU/PTV-coated group (A), along with quantitative cell viability assessments at 24 h (B) and 72 h (C). (D–E) Relative mRNA expression levels of α-SMA (D), VCAM-1(E), as determined by qPCR analysis. One-way ANOVA followed by Tukey's multiple comparison test was performed to determine statistical significance. Data are presented as mean ± SD, with p -values <0.05 considered statistically significant (n = 3). ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.
    Human Umbilical Artery Smooth Muscle Cells Smcs, supplied by PromoCell, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+umbilical+artery+smcs+huasmcs/HUASMC-c+Human+Umbilical+Artery+Smooth+Muscle+Cells/pm40778606-504-132-141
    Average 94 stars, based on 1 article reviews
    human umbilical artery smooth muscle cells smcs - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier
    primary human umbilical artery smcs (huasmcs)  (Lonza)
    90
    Lonza primary human umbilical artery smcs (huasmcs)
    Effects of bare and coating-modified groups on <t>SMCs</t> proliferation. (A–C) Representative fluorescence images of <t>HUASMCs</t> cytoskeleton (red) and nucleus (blue) after 24 and 72 h of different treatments, including untreated control group, bare group, MgF 2 -coated group, MgF 2 /PU-coated group, and MgF 2 /PU/PTV-coated group (A), along with quantitative cell viability assessments at 24 h (B) and 72 h (C). (D–E) Relative mRNA expression levels of α-SMA (D), VCAM-1(E), as determined by qPCR analysis. One-way ANOVA followed by Tukey's multiple comparison test was performed to determine statistical significance. Data are presented as mean ± SD, with p -values <0.05 considered statistically significant (n = 3). ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.
    Primary Human Umbilical Artery Smcs (Huasmcs), supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+umbilical+artery+smcs+huasmcs/human+umbilical+artery+smooth+muscle+cells/pm26987444-27-0-7
    Average 90 stars, based on 1 article reviews
    primary human umbilical artery smcs (huasmcs) - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    human umbilical artery smcs (huasmcs)  (ScienCell)
    90
    ScienCell human umbilical artery smcs (huasmcs)
    Effects of bare and coating-modified groups on <t>SMCs</t> proliferation. (A–C) Representative fluorescence images of <t>HUASMCs</t> cytoskeleton (red) and nucleus (blue) after 24 and 72 h of different treatments, including untreated control group, bare group, MgF 2 -coated group, MgF 2 /PU-coated group, and MgF 2 /PU/PTV-coated group (A), along with quantitative cell viability assessments at 24 h (B) and 72 h (C). (D–E) Relative mRNA expression levels of α-SMA (D), VCAM-1(E), as determined by qPCR analysis. One-way ANOVA followed by Tukey's multiple comparison test was performed to determine statistical significance. Data are presented as mean ± SD, with p -values <0.05 considered statistically significant (n = 3). ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.
    Human Umbilical Artery Smcs (Huasmcs), supplied by ScienCell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+umbilical+artery+smcs+huasmcs/human+umbilical+artery+smooth+muscle+cells/pm27959397-30-0-8
    Average 90 stars, based on 1 article reviews
    human umbilical artery smcs (huasmcs) - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    human umbilical artery smcs (huasmcs) (clonetics, lonza, cat. no. cc-2579)  (Lonza)
    90
    Lonza human umbilical artery smcs (huasmcs) (clonetics, lonza, cat. no. cc-2579)
    Effects of bare and coating-modified groups on <t>SMCs</t> proliferation. (A–C) Representative fluorescence images of <t>HUASMCs</t> cytoskeleton (red) and nucleus (blue) after 24 and 72 h of different treatments, including untreated control group, bare group, MgF 2 -coated group, MgF 2 /PU-coated group, and MgF 2 /PU/PTV-coated group (A), along with quantitative cell viability assessments at 24 h (B) and 72 h (C). (D–E) Relative mRNA expression levels of α-SMA (D), VCAM-1(E), as determined by qPCR analysis. One-way ANOVA followed by Tukey's multiple comparison test was performed to determine statistical significance. Data are presented as mean ± SD, with p -values <0.05 considered statistically significant (n = 3). ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.
    Human Umbilical Artery Smcs (Huasmcs) (Clonetics, Lonza, Cat. No. Cc 2579), supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+umbilical+artery+smcs+huasmcs/human+umbilical+artery+smooth+muscle+cells/pmc04059065-64-28-34
    Average 90 stars, based on 1 article reviews
    human umbilical artery smcs (huasmcs) (clonetics, lonza, cat. no. cc-2579) - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    human umbilical artery smcs (huasmcs)  (Lonza)
    90
    Lonza human umbilical artery smcs (huasmcs)
    Effects of bare and coating-modified groups on <t>SMCs</t> proliferation. (A–C) Representative fluorescence images of <t>HUASMCs</t> cytoskeleton (red) and nucleus (blue) after 24 and 72 h of different treatments, including untreated control group, bare group, MgF 2 -coated group, MgF 2 /PU-coated group, and MgF 2 /PU/PTV-coated group (A), along with quantitative cell viability assessments at 24 h (B) and 72 h (C). (D–E) Relative mRNA expression levels of α-SMA (D), VCAM-1(E), as determined by qPCR analysis. One-way ANOVA followed by Tukey's multiple comparison test was performed to determine statistical significance. Data are presented as mean ± SD, with p -values <0.05 considered statistically significant (n = 3). ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.
    Human Umbilical Artery Smcs (Huasmcs), supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+umbilical+artery+smcs+huasmcs/human+umbilical+artery+smooth+muscle+cells/pmc04059065-169-27-33
    Average 90 stars, based on 1 article reviews
    human umbilical artery smcs (huasmcs) - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    human umbilical artery smcs (huasmcs  (Lonza)
    90
    Lonza human umbilical artery smcs (huasmcs
    Effects of bare and coating-modified groups on <t>SMCs</t> proliferation. (A–C) Representative fluorescence images of <t>HUASMCs</t> cytoskeleton (red) and nucleus (blue) after 24 and 72 h of different treatments, including untreated control group, bare group, MgF 2 -coated group, MgF 2 /PU-coated group, and MgF 2 /PU/PTV-coated group (A), along with quantitative cell viability assessments at 24 h (B) and 72 h (C). (D–E) Relative mRNA expression levels of α-SMA (D), VCAM-1(E), as determined by qPCR analysis. One-way ANOVA followed by Tukey's multiple comparison test was performed to determine statistical significance. Data are presented as mean ± SD, with p -values <0.05 considered statistically significant (n = 3). ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.
    Human Umbilical Artery Smcs (Huasmcs, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+umbilical+artery+smcs+huasmcs/human+umbilical+artery+smooth+muscle+cells/pmc04059065-197-25-31
    Average 90 stars, based on 1 article reviews
    human umbilical artery smcs (huasmcs - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Effects of bare and coating-modified groups on SMCs proliferation. (A–C) Representative fluorescence images of HUASMCs cytoskeleton (red) and nucleus (blue) after 24 and 72 h of different treatments, including untreated control group, bare group, MgF 2 -coated group, MgF 2 /PU-coated group, and MgF 2 /PU/PTV-coated group (A), along with quantitative cell viability assessments at 24 h (B) and 72 h (C). (D–E) Relative mRNA expression levels of α-SMA (D), VCAM-1(E), as determined by qPCR analysis. One-way ANOVA followed by Tukey's multiple comparison test was performed to determine statistical significance. Data are presented as mean ± SD, with p -values <0.05 considered statistically significant (n = 3). ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.

    Journal: Bioactive Materials

    Article Title: A hierarchical MgF 2 /polyurethane/pitavastatin coating alleviates degradation and enhances endothelialization of bioresorbable magnesium alloy stents

    doi: 10.1016/j.bioactmat.2025.08.038

    Figure Lengend Snippet: Effects of bare and coating-modified groups on SMCs proliferation. (A–C) Representative fluorescence images of HUASMCs cytoskeleton (red) and nucleus (blue) after 24 and 72 h of different treatments, including untreated control group, bare group, MgF 2 -coated group, MgF 2 /PU-coated group, and MgF 2 /PU/PTV-coated group (A), along with quantitative cell viability assessments at 24 h (B) and 72 h (C). (D–E) Relative mRNA expression levels of α-SMA (D), VCAM-1(E), as determined by qPCR analysis. One-way ANOVA followed by Tukey's multiple comparison test was performed to determine statistical significance. Data are presented as mean ± SD, with p -values <0.05 considered statistically significant (n = 3). ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.

    Article Snippet: Human umbilical vein ECs (HUVECs), human umbilical artery SMCs (HUASMCs), and MΦs were obtained from Procell Life Science & Technology Co., Ltd. All cell lines were maintained and passaged in a cell culture incubator at 37 °C with 5 % CO 2 .

    Techniques: Modification, Fluorescence, Control, Expressing, Comparison